Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2018

  1. A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain

    Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 1061-1071

  2. Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)

    British Journal of Cancer, Vol. 119, Núm. 9, pp. 1052-1059

2017

  1. Should clinically meaningful outcomes in cancer be based on individual survival rather than median overall survival?

    Journal of Comparative Effectiveness Research, Vol. 6, Núm. 6, pp. 491-495

2016

  1. Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology

    Advances in Therapy, Vol. 33, Núm. 11, pp. 2059-2068

2015

  1. Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population

    Patient Preference and Adherence, Vol. 10

2003

  1. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

    Human Mutation, Vol. 22, Núm. 4, pp. 301-312

1989

  1. Alternate cyclic hormonotherapy in advanced breast cancer. Biological basis, an update of clinical results

    Folia Oncologica, Vol. 12, Núm. 1, pp. 3-11